PQ 234
234. Deputy Catherine Connolly asked the Minister for Health further to Parliamentary Question No. 333 of 16 December 2020, the status of the proposed reimbursement of Dupilumab for the treatment of atopic eczema; if the HSE drugs group January 2021 meeting has taken place to date; if so, if a decision on reimbursement was taken at the meeting; and if he will make a statement on the matter. [2128/21]
Introduced
14 January 2021
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
14 January 2021
Summary
234. Deputy Catherine Connolly asked the Minister for Health further to Parliamentary Question No. 333 of 16 December 2020, the status of the proposed reimbursement of Dupilumab for the treatment of atopic eczema; if the HSE drugs group January 2021 meeting has taken place to date; if so, if a decision on reimbursement was taken at the meeting; and if he will make a statement on the matter. [2128/21]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 14 January 2021
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2021-01-14/234/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2021-01-14/pq_234